title: [First case of Stevens-Johnson syndrome in a patient treated by Triomune in Abidjan, Côte d'lvoire].
abstract: The authors report the first case of Stevens-Johnson syndrome which has occurred in a 45 year old patient treated by Triomune containing névirapine. Triomune is used within the context of the African antiretroviral initiative access. It was a mild form whose evolution was favourable when nevirapine was stopped. The prevalence of this affection should increase with the larger use of nevirapine in our countries and the attention of both prescriber and patient must be requested.
authors.affiliation: Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Côte d'lvoire.
authors.forename: O
authors.initials: O
authors.lastname: Kra
authors.forename: V
authors.initials: V
authors.lastname: Bamba
authors.forename: E
authors.initials: E
authors.lastname: Ehui
authors.forename: A
authors.initials: A
authors.lastname: Tanon
authors.forename: N A
authors.initials: NA
authors.lastname: Kassi
authors.forename: G
authors.initials: G
authors.lastname: Nzunetu
authors.forename: E
authors.initials: E
authors.lastname: Bissagnene
authors.forename: A
authors.initials: A
authors.lastname: Kadio
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects*; D007560:Cote d'Ivoire; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019829:Nevirapine / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*
chemical_list: D019380:Anti-HIV Agents; D019829:Nevirapine